Skip to main content
CDC Website

Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT)

This fact sheet provides information regarding the 12-dose regimen for treating latent TB infection.
Audiences:
Adults
At Risk Persons
Non-U.S.-born persons
General Public
Persons with TB
Author:
Minnesota Department of Health Tuberculosis Program
Focus Area:
TB
Subjects:
Treatment Guidelines Materials
Patient Care
TB
Publication Date:
2016
Format:
Information Sheet
2 p.: col., ill.